STOCK COMPARISON
Scotts Miracle-Gro vs Corteva: Fair Value & Quality
Both stocks run through our valuation models. Here is how Scotts Miracle-Gro (SMG) and Corteva (CTVA) compare, as of Aug 10, 2026.
As of Aug 10, 2026, Fair Value Calculator sees Scotts Miracle-Gro as the less overvalued of the two: Scotts Miracle-Gro trades at $62.91 versus a fair value of $26.95 (-57%), while Corteva trades at $76.83 versus $27.81 (-64%).
Scotts Miracle-Gro
SMG · USD · Materials
-57%
upside to fair value
overvalued
Price$62.91
Fair Value$26.95
Quality64/100
Corteva
CTVA · USD · Materials
-64%
upside to fair value
overvalued
Price$76.83
Fair Value$27.81
Quality71/100
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
Scotts Miracle-GroCorteva
Valuation
18.0×P/E (TTM)46.3×
1.05×P/S (TTM)3.20×
—P/B2.37×
10.1×EV/EBITDA13.2×
0.89×PEG1.44×
4.1%Dividend yield0.9%
$2.64Dividend per share$0.72
Profitability
3%Net margin7%
28%Operating margin24%
-48%Return on equity5%
9%Return on assets4%
Growth
5%Revenue growth (YoY)11%
-4.5%Avg. growth/yr (3Y)-0.1%
-3.7%Avg. growth/yr (5Y)4.1%
Balance & size
—Debt / equity0.07×
$4BMarket cap$57B
weakGrowth qualityhealthy
Scotts Miracle-Gro leads: 7 to 5 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
Scotts Miracle-Groof which business quality 60 · market factors 41
Cortevaof which business quality 69 · market factors 58
ProfitabilityMargins and returns on capital today
59
30
Quality GrowthAre margins and returns improving?
72
48
CashflowEarnings quality: real cash, not paper profit
63
80
Fin. StrengthBalance sheet, leverage, solvency risk
33
74
InvestmentDisciplined investing over empire-building
98
97
Low VolatilityCalm price path (market factor)
26
84
MomentumPrice trend over the last 3–12 months (market factor)
47
45
52W MomentumDistance to the 52-week high (market factor)
49
51
Net IssuanceBuybacks instead of dilution
55
100
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
Scotts Miracle-Gro
DCF Models$31.33
Earnings-Based$25.55
Dividend Discount$32.96
Multiples$42.43
Growth DCF$35.58
Economic Profit$19.78
Growth Earnings$33.52
20 of 20 models see the stock below the current price.
Corteva
DCF Models$50.58
Earnings-Based$30.99
Dividend Discount$9.27
Multiples$35.54
Asset-Based$24.19
Growth DCF$57.96
Economic Profit$34.06
Growth Earnings$21.85
24 of 24 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Scotts Miracle-Gro
Bear $19.88Fair Value $26.95Bull $41.92
$62.91 = current price (white tick)
Corteva
Bear $20.86Fair Value $27.81Bull $34.76
$76.83 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Scotts Miracle-Gro · Materials
Quality score64 · Top 25%
Fair value upside-57% · below median
Corteva · Materials
Quality score71 · Top 25%
Fair value upside-64% · bottom 25%
Bottom line
As of Aug 10, 2026, Fair Value Calculator sees Scotts Miracle-Gro as the less overvalued of the two: Scotts Miracle-Gro trades at $62.91 versus a fair value of $26.95 (-57%), while Corteva trades at $76.83 versus $27.81 (-64%).
Corteva has the higher quality score (71/100).
See the full analysis →
More comparisons
Popular match-ups from the same sectors, all with fair value and quality score.
Free · Top-25 report
See the undervalued quality stocks every month
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
